| Disease ID | Disease name | Reference |
|---|
| MESH:C535464 |
Conotruncal cardiac defects |
PMID:25224535 |
| MESH:C536595 |
Alzheimer disease type 2 |
PMID:12106778 |
| MESH:C566627 |
Ceroid Lipofuscinosis, Neuronal, 6 |
PMID:23516525 |
| MESH:D000013 |
Congenital Abnormalities |
PMID:32353296 |
| MESH:D000015 |
Abnormalities, Multiple |
PMID:26125595 |
| MESH:D000067877 |
Autism Spectrum Disorder |
PMID:33765546 |
| MESH:D000072660 |
Teratozoospermia |
PMID:34822792 |
| MESH:D000077962 |
Body-Weight Trajectory |
PMID:30090589 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
PMID:1817796; PMID:28337565 |
| MESH:D001008 |
Anxiety Disorders |
PMID:21458486; PMID:34058180 |
| MESH:D001259 |
Ataxia |
PMID:34018660 |
| MESH:D001321 |
Autistic Disorder |
PMID:28569757 |
| MESH:D001523 |
Mental Disorders |
PMID:26586927 |
| MESH:D001724 |
Birth Weight |
PMID:25982381 |
| MESH:D001927 |
Brain Diseases |
PMID:19005224; PMID:7133291 |
| MESH:D001930 |
Brain Injuries |
PMID:21985864; PMID:38129942 |
| MESH:D001943 |
Breast Neoplasms |
PMID:18602537 |
| MESH:D002137 |
Calculi |
PMID:15829347 |
| MESH:D002292 |
Carcinoma, Renal Cell |
PMID:39294077 |
| MESH:D002653 |
Child Behavior Disorders |
PMID:27448389 |
| MESH:D002779 |
Cholestasis |
PMID:12700418 |
| MESH:D002869 |
Chromosome Aberrations |
PMID:17176674 |
| MESH:D003072 |
Cognition Disorders |
PMID:19337503; PMID:24885898 |
| MESH:D003731 |
Dental Caries |
PMID:19129982 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
PMID:19074809 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
PMID:27258818 |
| MESH:D003930 |
Diabetic Retinopathy |
PMID:19074809 |
| MESH:D004410 |
Dyslexia |
PMID:35940320 |
| MESH:D005317 |
Fetal Growth Retardation |
PMID:25982381 |
| MESH:D005832 |
Genital Diseases, Male |
PMID:12699903 |
| MESH:D005911 |
Gliosis |
PMID:19812365 |
| MESH:D006402 |
Hematologic Diseases |
PMID:30090589 |
| MESH:D006943 |
Hyperglycemia |
PMID:26689646 |
| MESH:D006965 |
Hyperplasia |
PMID:24845367 |
| MESH:D007247 |
Infertility, Female |
PMID:26125595 |
| MESH:D007674 |
Kidney Diseases |
PMID:23339144; PMID:30090589; PMID:32246071 |
| MESH:D007859 |
Learning Disabilities |
PMID:16393669; PMID:17662456; PMID:21453724; PMID:26616912 |
| MESH:D007960 |
Leukocyte Disorders |
PMID:30090589 |
| MESH:D008569 |
Memory Disorders |
PMID:17662456; PMID:21453724; PMID:32659473 |
| MESH:D008661 |
Metabolism, Inborn Errors |
PMID:23452774 |
| MESH:D009069 |
Movement Disorders |
PMID:16551646; PMID:18234737; PMID:19337503 |
| MESH:D009369 |
Neoplasms |
PMID:17916923 |
| MESH:D009410 |
Nerve Degeneration |
PMID:16551646; PMID:16934782; PMID:18206288; PMID:18284614; PMID:19607852; PMID:20188756; PMID:20865164; PMID:22542671; PMID:30336192; PMID:32659473; PMID:33314588; PMID:38129942 |
| MESH:D009422 |
Nervous System Diseases |
PMID:23452774 |
| MESH:D009461 |
Neurologic Manifestations |
PMID:2204694 |
| MESH:D009765 |
Obesity |
PMID:25867198 |
| MESH:D009784 |
Occupational Diseases |
PMID:21307282; PMID:23721876 |
| MESH:D009845 |
Oligospermia |
PMID:34822792 |
| MESH:D010009 |
Osteochondrodysplasias |
PMID:24578216 |
| MESH:D010182 |
Pancreatic Diseases |
PMID:32246071 |
| MESH:D010300 |
Parkinson Disease |
PMID:11181820; PMID:23721876 |
| MESH:D010302 |
Parkinson Disease, Secondary |
PMID:22281203; PMID:22285144 |
| MESH:D011014 |
Pneumonia |
PMID:19263519 |
| MESH:D011230 |
Precancerous Conditions |
PMID:10222400 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
PMID:21458486; PMID:2204694 |
| MESH:D011507 |
Proteinuria |
PMID:33670331 |
| MESH:D011596 |
Psychomotor Disorders |
PMID:22427945 |
| MESH:D011629 |
Puberty, Precocious |
PMID:23997110; PMID:24845367 |
| MESH:D012140 |
Respiratory Tract Diseases |
PMID:19084589; PMID:20152896 |
| MESH:D012608 |
Scrapie |
PMID:11701772; PMID:19486493 |
| MESH:D013158 |
Splenic Diseases |
PMID:30090589; PMID:32246071 |
| MESH:D015431 |
Weight Loss |
PMID:32445656; PMID:37415728 |
| MESH:D019189 |
Iron Metabolism Disorders |
PMID:21458486 |
| MESH:D019636 |
Neurodegenerative Diseases |
PMID:15488650; PMID:17084486; PMID:19337503; PMID:29429640; PMID:38129942 |
| MESH:D019954 |
Neurobehavioral Manifestations |
PMID:12387356; PMID:19812362; PMID:23832297 |
| MESH:D019957 |
Motor Skills Disorders |
PMID:25451970; PMID:25601986; PMID:26968381; PMID:28610743 |
| MESH:D019958 |
Attention Deficit and Disruptive Behavior Disorders |
PMID:25451971 |
| MESH:D019964 |
Mood Disorders |
PMID:21312047 |
| MESH:D020149 |
Manganese Poisoning |
PMID:12009774; PMID:12171760; PMID:15010209; PMID:15183009; PMID:15681813; PMID:16393669; PMID:16417967; PMID:16551646; PMID:16568477; PMID:16934782; PMID:17467022; PMID:17615110; PMID:17662456; PMID:18041089; PMID:18284614; PMID:18771689; PMID:19383943; PMID:19453300; PMID:20188756; PMID:20648640; PMID:20865164; PMID:21107535; PMID:21310168; PMID:21384399; PMID:21493178; PMID:21812036; PMID:22281203; PMID:22285144; PMID:25149416; PMID:29429640; PMID:33012730 |
| MESH:D020258 |
Neurotoxicity Syndromes |
PMID:15488650; PMID:17977900; PMID:18684773; PMID:38129942 |
| MESH:D020734 |
Parkinsonian Disorders |
PMID:16140633; PMID:16991145; PMID:17060373; PMID:19607852; PMID:20798247; PMID:20876035; PMID:22975163; PMID:23313730; PMID:23385959; PMID:24060432; PMID:24614235; PMID:26220508 |
| MESH:D047928 |
Premature Birth |
PMID:25342170 |
| MESH:D049188 |
Prenatal Injuries |
PMID:26125595 |
| MESH:D050177 |
Overweight |
PMID:25867198 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:32246071 |
| MESH:D058225 |
Plaque, Amyloid |
PMID:18284614; PMID:20188756 |
| MESH:D058625 |
End Stage Liver Disease |
PMID:10206825; PMID:10564534; PMID:15025246 |
| MESH:D065886 |
Neurodevelopmental Disorders |
PMID:29429640 |
| MESH:D066126 |
Cardiotoxicity |
PMID:32246071 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.